Global Micro-RNA Sequencing and Assay Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Micro-RNA Sequencing and Assay Market Insights, Forecast to 2034
MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.Like other miRNA profiling technologies, miRNA-Seq has both advantages (sequence-independence, coverage) and disadvantages (high cost, infrastructure requirements, run length, and potential artifacts).
Market Analysis and InsightsGlobal Micro-RNA Sequencing and Assay Market
Global Micro-RNA Sequencing and Assay market is expected to reach to US$ 245 million in 2023, with a positive growth of %, compared with US$ 231 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Micro-RNA Sequencing and Assay industry is evaluated to reach US$ 429.3 million in 2033. The CAGR will be 9.8% during 2023 to 2033.
Globally, Micro-RNA Sequencing and Assay key companies include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. Illumina, Thermo Fisher Scientific, QIAGEN are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Micro-RNA Sequencing and Assay were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Micro-RNA Sequencing and Assay market and estimated to attract more attentions from industry insiders and investors.
Micro-RNA Sequencing and Assay can be divided into Sequencing by Synthesis, Sequencing by Nanopore and Ion Semiconductor Sequencing,, etc. Sequencing by Synthesis is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Micro-RNA Sequencing and Assay is widely used in various fields, such as Research Institute, Academia and CRO,, etc. Research Institute provides greatest supports to the Micro-RNA Sequencing and Assay industry development. In 2022, global % revenue of Micro-RNA Sequencing and Assay went into Research Institute filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Micro-RNA Sequencing and Assay market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Micro-RNA Sequencing and Assay market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Segment by Type
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Research Institute
Academia
CRO
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Micro-RNA Sequencing and Assay introduction, etc. Micro-RNA Sequencing and Assay Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Micro-RNA Sequencing and Assay
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Micro-RNA Sequencing and Assay Market
Global Micro-RNA Sequencing and Assay market is expected to reach to US$ 245 million in 2023, with a positive growth of %, compared with US$ 231 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Micro-RNA Sequencing and Assay industry is evaluated to reach US$ 429.3 million in 2033. The CAGR will be 9.8% during 2023 to 2033.
Globally, Micro-RNA Sequencing and Assay key companies include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. Illumina, Thermo Fisher Scientific, QIAGEN are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Micro-RNA Sequencing and Assay were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Micro-RNA Sequencing and Assay market and estimated to attract more attentions from industry insiders and investors.
Micro-RNA Sequencing and Assay can be divided into Sequencing by Synthesis, Sequencing by Nanopore and Ion Semiconductor Sequencing,, etc. Sequencing by Synthesis is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Micro-RNA Sequencing and Assay is widely used in various fields, such as Research Institute, Academia and CRO,, etc. Research Institute provides greatest supports to the Micro-RNA Sequencing and Assay industry development. In 2022, global % revenue of Micro-RNA Sequencing and Assay went into Research Institute filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Micro-RNA Sequencing and Assay market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Micro-RNA Sequencing and Assay market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Segment by Type
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Segment by Application
Research Institute
Academia
CRO
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Micro-RNA Sequencing and Assay introduction, etc. Micro-RNA Sequencing and Assay Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Micro-RNA Sequencing and Assay
Chapter 13Methodology and Data Sources adopted by MRAResearch